Patent Application
20240115313
The present specification generally relates to systems, methods, and catheters for treatment of a blood vessel and, more specifically, systems, methods, and catheters for endovascular treatment of a blood vessel.
Endovascular treatments treat various blood vessel disorders from within the blood vessel using long, thin tubes called catheters, which are place inside the blood vessel to deliver the treatment. Endovascular treatments may include, but are not limited to, endovascular arteriovenous fistula (endoAVF) formations, arteriovenous (AV) treatments, and peripheral arterial disease (PAD) treatments. One of the most challenging aspects of endovascular treatment is proper alignment of a treatment portion of a catheter with the correct treatment location of the blood vessel. Additionally, treatments such as endovascular fistula formation may require two catheters positioned within adjacent blood vessels to form a fistula therebetween. However, alignment and position of two separate catheters may also be difficult/cumbersome for a practitioner.
Additionally, imaging systems for visualizing catheter alignment within blood vessels may also provide numerous hurdles to overcome. In particular fluoroscopy equipment is very expensive, accordingly such equipment might not be available outside of an operating room or in rural locations. Moreover, repeated use of fluoroscopy equipment may introduce radiation not only to the patient but also to the physician. Overtime, such repeat exposure may impact the physician's health. Additionally, contrast dyes used in fluoroscopy may not be suitable for patients with certain medical conditions (e.g., chronic kidney disease).
Accordingly, a need exists for alternative systems, methods, and catheters for endovascular treatment of a blood vessel that improve alignment techniques of the catheter within the blood vessel, and or catheters for endovascular treatment of a blood vessel that allow for simpler delivery of treatment to the blood vessel.
The present embodiments address the above referenced problems. In particular, the present disclosure is directed to systems, methods, and catheters to improved visualization and alignment techniques for delivery of treatments (e.g., fistula formation) using one or more catheters to a blood vessel. Additionally, some embodiments are directed to single catheter systems which may reduce complexity of current two catheter systems.
In a first aspect, a system for endovascular treatment of a blood vessel includes a control unit, an ultrasound device, an actuator, and a catheter having a treatment portion. The ultrasound device is communicatively coupled to the control unit. The ultrasound device includes an ultrasound probe having a subject contact surface. The actuator is coupled to the ultrasound probe and is operable to move the subject contact surface of the ultrasound prove relative to a treatment zone of a subject. The control unit is configured to determine a position of the treatment portion of the catheter as the catheter is advanced through the blood vessel, and move the subject contact surface of the ultrasound probe relative to the treatment zone of the subject with the actuator to follow the position of the catheter as the catheter is advanced through the blood vessel.
In a second aspect, the present disclosure includes a system according to the first aspect, further including one or more user input devices communicatively coupled to the control unit, wherein the control unit is further configured to: received user input from the one or more user input device, and switch to a manual operation mode from an automatic following mode to allow for manual control of movement of the ultrasound probe based on input from the one or more user input devices.
In a third aspect, the present disclosure includes a system according to any preceding aspect, further including a display communicatively coupled to the control unit wherein the control unit is further configured to display one or more ultrasound images with the display in real time as the catheter is advanced through the blood vessel.
In a fourth aspect, the present disclosure includes a system according to the third aspect, wherein the control unit is further configured to determine an orientation of the treatment portion of the catheter within the blood vessel and output an indication of the orientation of the treatment portion of the catheter with the display.
In a fifth aspect, the present disclosure includes a system according to any preceding aspect, wherein the ultrasound device is a 3D ultrasound device and the control unit is configured to display two or more of a frontal plane ultrasound image, an axial plane ultrasound image, and sagittal plane ultrasound image.
In a sixth aspect, the present disclosure includes a system according to any preceding aspect, wherein the ultrasound device is a 3D ultrasound device and the control unit is configured to recognize one or more vessels within an ultrasound image of the ultrasound device and display a 3D model of the one or more vessels on the display.
In a seventh aspect, the present disclosure includes a system according to any preceding aspect, further including a media bath configured to be placed over a treatment zone of a subject, wherein the ultrasound device moves within the media bath.
In an eighth aspect, the present disclosure includes a system according to the seventh aspect, wherein the media bath comprises a flexible subject interface, wherein the flexible subject interface conforms to a shape of the treatment zone of the subject.
In a ninth aspect, the present disclosure includes a system according to the seventh aspect or the eighth aspect, wherein the media bath comprises a housing comprising a track, wherein the ultrasound device is moveable along the track.
In a tenth aspect, the present disclosure includes a system according to any preceding aspect, wherein the catheter comprises a housing, a cutting device, and a biasing mechanism coupled to the housing of the catheter and configured to bias the cutting device against a wall of the blood vessel.
In an eleventh aspect, the present disclosure includes a system according to the tenth aspect, wherein the biasing mechanism is a balloon.
In a twelfth aspect, the present disclosure includes a system according to the tenth aspect, wherein the biasing mechanism is an expandable cage.
In a thirteenth aspect, the present disclosure includes a system according to any of the tenth through twelfth aspects, wherein the biasing mechanism comprises one or more expandable wires moveable between a collapsed position and an expanded position wherein at least a portion of the one or more expandable wire are spaced from an outer wall of the housing of the catheter.
In a fourteenth aspect, the present disclosure includes a system according to any of the tenth through the thirteenth aspects, wherein the catheter comprises one or more echogenic markers, wherein the one or more echogenic markers indicate a rotational alignment of cutting device of the catheter.
In a fifteenth aspect, a system for endovascular treatment of a blood vessel includes a control unit, an imaging device, a display, and a catheter having a treatment portion. The imaging device and the display are communicatively coupled to the control unit. The control unit is configured to display an image of the blood vessel, determine a rotational orientation of the treatment portion of the catheter within the blood vessel, and output an indication of the rotational orientation of the treatment portion of the catheter with the display.
In a sixteenth aspect, the present disclosure includes a system according to the fifteenth aspect, wherein the indication comprises an overlay projected over the image of the blood vessel, the overlay providing an indicator of the rotational orientation of the treatment portion of the catheter.
In a seventeenth aspect, the present disclosure includes a system according to the fifteenth aspect or the sixteenth aspect, wherein the imaging device is an ultrasound imaging device.
In an eighteenth aspect, the present disclosure includes a system according to any of the fifteenth aspect through the seventeenth aspect, wherein the imaging device is an intravascular imaging device.
In a nineteenth aspect, the present disclosure includes a system according to any of the fifteenth aspect through the eighteenth aspect, wherein the imaging device is coupled to the catheter at a position distal to the treatment portion.
In a twentieth aspect, the present disclosure includes a system according to any of the fifteenth aspect through the nineteenth aspect, wherein the imaging device is coupled to the catheter at a position proximal to the treatment portion.
In a twenty-first aspect, the present disclosure includes a system according to any of the fifteenth aspect through the twentieth aspect, wherein the imaging device is a 3D ultrasound device and the control unit is configured to display two or more of a frontal plane ultrasound image, an axial plane ultrasound image, and sagittal plane ultrasound image with the display.
In a twenty-second aspect, the present disclosure includes a system according to any of the fifteenth aspect through the twenty-first aspect, wherein the ultrasound device is a 3D ultrasound device and the control unit is configured to recognize one or more vessels within an ultrasound image of the ultrasound device and display a 3D model of the one or more vessels on the display.
In a twenty-third aspect, the present disclosure includes a system according to any of the fifteenth aspect through the twenty-second aspect, wherein the catheter comprises a housing, wherein the treatment portion of the catheter is coupled to the housing of the catheter at a first radial position.
In a twenty-fourth aspect, the present disclosure includes a system according to the twenty-third aspect, wherein the catheter further comprises a biasing mechanism coupled to the housing of the catheter, the biasing mechanism configured to bias the treatment portion of the catheter toward a wall of the blood vessel.
In a twenty-fifth aspect, the present disclosure includes a system according to the twenty-fourth aspect, wherein the biasing mechanism is coupled to the housing of the catheter proximate to the treatment portion.
In a twenty-sixth aspect, the present disclosure includes a system according to any of the fifteenth aspect through the twenty-fifth aspect, wherein the treatment portion comprises a cutting device.
In a twenty-seventh aspect, the present disclosure includes a system according to any of the twenty-fourth aspect through the twenty-sixth aspect when depending on the twenty-fourth aspect, wherein the biasing mechanism is a balloon.
In a twenty-ninth aspect, the present disclosure includes a system according to any of the twenty-fourth aspect through the twenty-sixth aspect when depending on the twenty-fourth aspect, wherein the biasing mechanism comprises one or more expandable wires moveable between a collapsed position and an expanded position wherein at least a portion of the one or more expandable wire are spaced from an outer wall of the housing of the catheter.
In a thirtieth aspect, the present disclosure includes a system according to any of the fifteenth aspect through the twenty-ninth aspect, wherein the catheter comprises one or more echogenic markers, wherein the one or more echogenic markers indicate a rotational alignment of cutting device of the catheter.
In a thirty-first aspect, the present disclosure includes a catheter for endovascular treatment of a blood vessel includes a housing, a treatment portion coupled to the housing, an intravascular imaging device coupled to the housing, and a biasing mechanism coupled to the housing. The biasing mechanism is configured to contact a wall of the blood vessel to bias the treatment portion into contact with the wall of the blood vessel.
In a thirty-second aspect, the present disclosure includes a system according to the thirty-first aspect, wherein the biasing mechanism is configured to contact a first radial portion of the wall of the blood vessel to bias the treatment portion toward a second radial portion of the wall of the blood vessel opposite the first radial portion.
In a thirty-third aspect, the present disclosure includes a system according to the thirty-first aspect or the thirty-second aspect, wherein the intravascular imaging device is coupled to the housing of the catheter at a position distal to the treatment portion.
In a thirty-fourth aspect, the present disclosure includes a system according to the thirty-first aspect or the thirty-second aspect, wherein the intravascular imaging device is coupled to the housing of the catheter at a position proximal to the treatment portion.
In a thirty-fifth aspect, the present disclosure includes a system according to the thirty-first aspect or the thirty-second aspect, wherein the intravascular imaging device is coupled to the housing of the catheter at a position longitudinally aligned with the treatment portion of the catheter.
In a thirty-sixth aspect, the present disclosure includes a system according to any of the thirty-first aspect through the thirty-fifth aspect, wherein the treatment portion comprises an electrode comprising an arc that extends from the housing, and wherein the intravascular imaging device is positioned so as to capture image data of a cross-section of the catheter taken perpendicular to a longitudinal direction of the catheter at a apex of the arc.
In a thirty-seventh aspect, the present disclosure includes a system according to any of the thirty-first aspect through the thirty-sixth aspect, wherein the intravascular imaging device is positioned longitudinally within the treatment portion of the catheter.
In a thirty-eighth aspect, the present disclosure includes a system according to any of the thirty-first aspect through the thirty-seventh aspect, wherein the treatment portion comprises an electrode, wherein the intravascular imaging device is positioned longitudinally with the treatment portion of the catheter, so as to capture image data of a cross-section of the electrode.
In a thirty-ninth aspect, the present disclosure includes a system according to any of the thirty-first aspect through the thirty-eighth aspect, wherein the biasing mechanism is coupled to the housing of the catheter proximate to the treatment portion.
In a fortieth aspect, the present disclosure includes a system according to any of the thirty-first aspect through the thirty-ninth aspect, wherein the treatment portion comprises a cutting device.
In a forty-first aspect, the present disclosure includes a system according to any of the thirty-first aspect through the fortieth aspect, wherein the biasing mechanism is a balloon.
In a forty-second aspect, the present disclosure includes a system according to any of the thirty-first aspect through the fortieth aspect, where in the biasing mechanism is an expandable cage.
In a forty-third aspect, a method for endovascular treatment of a blood vessel includes advancing a catheter within the blood vessel to a treatment location of the blood vessel, aligning a treatment portion of the catheter with the treatment location of the blood vessel, and deploying the catheter with a biasing mechanism coupled to a body of the catheter. The biasing mechanism is configured to contact a first radial portion of the blood vessel to bias the treatment portion of the catheter toward the treatment location of the blood vessel opposite the first radial portion.
In a forty-fourth aspect, the present disclosure includes a method according to the forty-third aspect, wherein the treatment portion comprises a cutting device.
In a forty-fifth aspect, the present disclosure includes a method according to the forty-third aspect or the forty-fourth aspect, wherein the biasing mechanism is a balloon.
In a forty-sixth aspect, the present disclosure includes a method according to the forty-third aspect or the forty-fourth aspect, where in the biasing mechanism is an expandable cage.
In a forty-seventh aspect, the present disclosure includes a method according to any of the forty-third aspect through the forty-sixth aspect, wherein the biasing mechanism is coupled to the housing of the catheter proximate to the treatment portion.
In a forty-eighth aspect, the present disclosure includes a method according to any of the forty-third aspect through the forty-seventh aspect, further including determining a position of the treatment portion of the catheter as the catheter is advanced through the blood vessel with a control unit, moving an imaging device with an actuator to follow the position of the catheter as the catheter is advanced through the blood vessel, and displaying one or more images from the imaging device with a display in real time as the catheter is advanced through the blood vessel.
In a forty-ninth aspect, the present disclosure includes a method according to any of the forty-third aspect through the forty-eighth aspect, further including capturing image data with an imaging device coupled to the catheter, and displaying image data from the imaging device with a display in real time as the catheter is advanced through the blood vessel.
In a fiftieth aspect, the present disclosure includes a method according to any of the forty-third aspect through the forty-ninth aspect, further including determining a rotational alignment of the catheter, and displaying an indication of the rotational alignment of the catheter with the display.
In a fifty-first aspect, the present disclosure includes a method according to any of the forty-third aspect through the fiftieth aspect, further including determining a rotational alignment of the treatment portion of the catheter, and displaying an indication of the rotational alignment of the treatment portion of the catheter with the display.
In a fifty-second aspect, the present disclosure includes a method according to any of the forty-third aspect through the fifty-first aspect, further including automatically adjusting the imaging device to automatically focus the imaging device on the treatment portion of the catheter to adjust image quality using one or more location sensors and/or echogenic markers.
In a fifty-third aspect, the present disclosure includes a system according to any of the fifteenth through thirtieth aspect, wherein the imaging device is an ultrasound device, and the control unit is configured to: recognize an arterial blood flow using a Doppler functionality of the ultrasound device; recognize a venous blood flow using the Doppler Functionality of the ultrasound device; and display a blood vessel map based on the arterial blood flow and the venous blood flow.
In a fifty-fourth aspect, the present disclosure includes a system according to the fifty-third aspect, wherein the arterial blood flow is depicted as a first color and the venous blood flow is depicted as a second color different from the first color in the blood vessel map.
In a fifty-fifth aspect, the present disclosure includes a system according to the fifty-third aspect or the fifty-fourth aspect, wherein the control unit is configured to recognize fistula creation by identifying blood flow between an adjacent artery and vein using the Doppler functionality of the ultrasound device.
In a fifty-sixth aspect, the present disclosure include a control unit for endovascular treatment of a blood vessel with one or more catheters. The control unit includes one or more process and one or more memory modules communicatively coupled to the one or more processors. The control unit is configured to be communicatively coupled to an imaging device and a display. When the one or more processors execute logic stored on the one or more memory modules, the control unit displays the image data from the imaging device of a blood vessel, determines a rotational orientation of a treatment portion of a catheter within a blood vessel, and outputs an indication of the rotational orientation of the treatment portion of the catheter with the display.
In a fifty-seventh aspect, the present disclosure includes a control unit according to the fifty-sixth aspect, wherein the indication comprises an overlay projected over the image of the blood vessel, the overlay providing an indicator of a rotational orientation of the treatment portion of the catheter.
In a fifty-eighth aspect, the present disclosure includes a control unit according to the fifty-sixth aspect or the fifty-seventh aspect, wherein the imaging device is an ultrasound imaging device.
In a fifty-ninth aspect, the present disclosure includes a control unit according to any of the fifty-sixth aspect through the fifty-eighth aspect, wherein the imaging device is an intravascular imaging device.
In a sixtieth aspect, the present disclosure includes a control unit according to any of the fifty-sixth aspect through the fifty-ninth aspect, wherein the imaging device is coupled to the catheter at a position distal to the treatment portion.
In a sixty-first aspect, the present disclosure includes a control unit according to any of the fifty-sixth aspect through the fifty-ninth aspect, wherein the imaging device is coupled to the catheter at a position proximal to the treatment portion.
In a sixty-second aspect, the present disclosure includes a control unit according to any of the fifty-sixth aspect through the sixty-first aspect, wherein the imaging device is a 3D ultrasound device and the control unit is configured to display two or more of a frontal plane ultrasound image, an axial plane ultrasound image, and sagittal plane ultrasound image with the display.
In a sixty-third aspect, the present disclosure includes a control unit according to any of the fifty-sixth aspect through the sixty-second aspect, wherein the ultrasound device is a 3D ultrasound device and the control unit is configured to recognize one or more vessels within an ultrasound image of the ultrasound device and display a 3D model of the one or more vessels on the display.
In a sixty-fourth aspect, the present disclosure includes a control unit according to any of the fifty-sixth aspect through the sixty-third aspect, wherein the control unit is configured to be communicatively coupled to one or more location sensors coupled to the catheter, the one or more location sensors outputting a location signal indicative of a location of the treatment portion, wherein the control unit is configured to determine a location of the treatment portion based on the signal from the one or more location sensors.
In a sixty-fifth aspect, the present disclosure includes a control unit according to any of the fifty-sixth aspect through the sixty-fourth aspect, wherein the imaging device is an ultrasound device, and the control unit is configured to: recognize an arterial blood flow using a Doppler functionality of the ultrasound device; recognize a venous blood flow using the Doppler functionality of the ultrasound device; and display a blood vessel map based on the arterial blood flow and the venous blood flow.
In a sixty-sixth aspect, the present disclosure includes a control unit according to the sixty-fifth aspect, wherein the arterial blood flow is depicted as a first color and the venous blood flow is depicted as a second color different from the first color in the blood vessel map.
In a sixty-seventh aspect, the present disclosure includes a control unit according to any of the fifty-sixth aspect through the sixty-sixth aspect, herein the control unit is configured to recognize fistula creation by identifying blood flow between an adjacent artery and vein using the Doppler functionality of the ultrasound device.
In a sixty-eighth aspect, the present disclosure includes a control unit for endovascular treatment of a blood vessel using one or more catheters. The control unit includes one or more processors and one or more memory modules communicatively coupled to the one or more processors. The control unit is configured to be communicatively coupled to an ultrasound probe having a subject contact surface, and an actuator coupled to the ultrasound probe. When the one or more processors execute logic stored on the one or more memory modules, the control unit determines a position of a treatment portion of a catheter as the catheter is advanced through the blood vessel; and moves a subject contact surface of the ultrasound probe relative to the treatment zone of the subject with the actuator to follow the position of the catheter as the catheter is advanced through the blood vessel.
In a sixty-ninth aspect, the present disclosure includes a control unit according to the sixty-eight aspect, wherein the control unit is configured to be communicatively coupled to one or more user input devices, wherein the control unit is further configured to: receive user input from the one or more user input devices; and switch to a manual operation mode from an automatic following mode to allow for manual control of movement of the ultrasound probe based on input from the one or more user input devices.
In a seventieth aspect, the present disclosure includes a control unit according to the sixty-eight aspect or the sixty-ninth aspect, wherein the control unit is configured to be communicatively coupled to a display, wherein the control unit is further configured to: display one or more ultrasound images with the display in real time as the catheter is advanced through the blood vessel.
In a seventy-first aspect, the present disclosure includes a control unit according to any of the sixty-eighth aspect through the seventieth aspect, wherein the control unit is further configured to determine an orientation of the treatment portion of the catheter within the blood vessel and output an indication of the orientation of the treatment portion of the catheter with the display.
In a seventy-second aspect, the present disclosure includes a control unit according to any of the sixty-eighth aspect through the seventy-first aspect, wherein the ultrasound device is a 3D ultrasound device and the control unit is configured to display two or more of a frontal plane ultrasound image, an axial plane ultrasound image, and sagittal plane ultrasound image.
In a seventy-third aspect, the present disclosure includes a control unit according to any of the sixty-eighth aspect through the seventy-second aspect, wherein the ultrasound device is a 3D ultrasound device and the control unit is configured to recognize one or more vessels within an ultrasound image of the ultrasound device and display a 3D model of the one or more vessels on the display.
In a seventy-fourth aspect, the present disclosure includes a control unit according to any of the sixty-eight aspect through the seventy-third aspect, wherein the catheter comprises one or more echogenic markers, and the control unit is configured to determine a rotational orientation of the catheter based on recognition of the one or more echogenic markers.
In a seventy-fifth aspect, the present disclosure includes a control unit according to any of the sixty-eight aspect through the seventy-fourth aspect, wherein the control unit is configured to be communicatively coupled to one or more location sensors coupled to the catheter, the one or more location sensors outputting a location signal indicative of a location of the treatment portion, wherein the control unit is configured to determine a location of the treatment portion based on the signal from the one or more location sensors.
In a seventy-sixth aspect, the present disclosure includes a catheter for endovascular treatment of a blood vessel, the catheter comprising: a housing; a treatment portion; a fistula forming element; and an intravascular ultrasound imaging device.
In a seventy-seventh aspect, the present disclosure includes the catheter according to the seventy-sixth aspect, wherein the intravascular ultrasound imaging device further comprises an array of solid-state transducers.
In a seventy-eighth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through seventy-seventh aspects, wherein the array of solid-state transducers are disposed distal the fistula forming element.
In a seventy-ninth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through seventy-eighth aspects, wherein the array of solid-state transducers are disposed proximal the fistula forming element.
In an eightieth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through seventy-ninth aspects, wherein the array of solid-state transducers are coupled to the housing of the catheter.
In an eighty-first aspect, the present disclosure includes the catheter according to any of the seventy-sixth through eightieth aspects, wherein the array of solid-state transducers are disposed circumferentially around the housing of the catheter.
In an eighty-second aspect, the present disclosure includes the catheter according to any of the seventy-sixth through eighty-first aspects, wherein the intravascular ultrasound imaging device further comprises one or more flexible circuit elements electrically coupled to the array of solid-state transducers.
In an eighty-third aspect, the present disclosure includes the catheter according to any of the seventy-sixth through eighty-second aspects, wherein the one or more flexible circuit elements further comprise one or more multiplexing application-specific integrated circuits.
In an eighty-fourth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through eighty-third aspects, wherein the one or more flexible circuit elements are positioned within the housing of catheter.
In an eighty-fifth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through eighty-fourth aspects, further comprising an intravascular ultrasound imaging device wire extending proximally from the one or more flexible circuit elements through the housing of the catheter.
In an eighty-sixth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through eighty-fifth aspects, wherein the one or more flexible circuit elements are positioned distal the fistula forming element and proximal the array of solid-state transducers.
In an eighty-seventh aspect, the present disclosure includes the catheter according to any of the seventy-sixth through eighty-sixth aspects, wherein: the one or more flexible circuit elements are positioned proximal the array of solid-state transducers; and the array of solid-state transducers are positioned proximal the fistula forming element.
In an eighty-eighth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through eighty-seventh aspects, wherein the fistula forming element is an electrode configured to ablate tissue.
In an eighty-ninth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through eighty-eighth aspects, wherein: the electrode housing is positioned along the treatment portion of the catheter; and the electrode housing is at least partially positioned within the housing of the catheter.
In a ninetieth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through eighty-ninth aspects, wherein the electrode is housed within the electrode housing when the electrode is in a low-profile configuration.
In a ninety-first aspect, the present disclosure includes the catheter according to any of the seventy-sixth through ninetieth aspects, wherein the electrode is configured to radially extend from the electrode housing and the housing of the catheter when the electrode is in an extended configuration.
In a ninety-second aspect, the present disclosure includes the catheter according to any of the seventy-sixth through ninety-first aspects, wherein the electrode is spring biased from a low-profile configuration, wherein the electrode is housed within the electrode housing, to an extended configuration, wherein the electrode radially extends from the electrode housing and the housing of the catheter.
In a ninety-third aspect, the present disclosure includes the catheter according to any of the seventy-sixth through ninety-second aspects, wherein the intravascular ultrasound imaging device further comprises: an array of solid-state transducers; one or more flexible circuit elements electrically coupled to the array of solid-state transducers; and an intravascular ultrasound imaging device wire extending proximally from the one or more flexible circuit elements through the housing of the catheter.
In a ninety-fourth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through ninety-third aspects, wherein: the electrode housing further comprises a channel extending therethrough; the array of solid-state transducers are positioned distal the electrode housing; the one or more flexible circuit elements are positioned distal the electrode housing; and the intravascular ultrasound imaging device wire extends through the channel extending through the electrode housing.
In a ninety-fifth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through ninety-fourth aspects, further comprising: a first lumen extending through the housing of the catheter; and a second lumen extending through the housing of the catheter, wherein: the electrode further comprises an electrode wire electrically coupled to the electrode and extending proximally from the electrode through the housing of the catheter in the first lumen; and the intravascular ultrasound imaging device wire extends through the second lumen.
In a ninety-sixth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through ninety-fifth aspects, wherein the first lumen further comprises an insulation sleeve.
In a ninety-seventh aspect, the present disclosure includes the catheter according to any of the seventy-sixth through ninety-sixth aspects, further comprising a biasing mechanism coupled to the housing, wherein the biasing mechanism is configured to contact a wall of the blood vessel to bias the treatment portion into contact with the wall of the blood vessel.
In a ninety-eighth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through ninety-seventh aspects, wherein the biasing mechanism is configured to contact a first radial portion of the wall of the blood vessel to bias the treatment portion toward a second radial portion of the wall of the blood vessel opposite the first radial portion.
In a ninety-ninth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through ninety-eighth aspects, wherein the biasing mechanism is a balloon.
In a one-hundredth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through ninety-ninth aspects, wherein the biasing mechanism is an expandable cage.
In a one-hundred-first aspect, the present disclosure includes the catheter according to any of the seventy-sixth through one-hundredth aspects, wherein the biasing mechanism comprises one or more expandable wires moveable between a collapsed position and an expanded position wherein at least a portion of the one or more expandable wires are spaced from an outer wall of the housing of the catheter.
In a one-hundred-second aspect, the present disclosure includes the catheter according to any of the seventy-sixth through one-hundred-first aspects, wherein the housing further comprises a rapid exchange tip at a distal end of the catheter.
In a one-hundred-third aspect, the present disclosure includes the catheter according to any of the seventy-sixth through one-hundred-second aspects, wherein the housing is comprised of one or more polymers.
In a one-hundred-fourth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through one-hundred-third aspects, wherein the housing is comprised of silicone rubber, nylon, polyurethane, polyethylene terephthalate, latex, or thermoplastic elastomers.
In a one-hundred-fifth aspect, the present disclosure includes the catheter according to any of the seventy-sixth through one-hundred-fourth aspects, wherein the housing is further comprised of a braided polymer.
In a one-hundred-sixth aspect, the present disclosure includes a method for forming a fistula in a blood vessel, the method comprising: advancing a catheter within the blood vessel to a treatment location of the blood vessel; generating an image of the blood vessel from data collected from an intravascular ultrasound imaging device of the catheter; aligning a treatment portion of the catheter with the treatment location of the blood vessel; deploying the catheter with a biasing mechanism coupled to a housing of the catheter, wherein the biasing mechanism is configured to contact a first radial portion of the blood vessel to bias the treatment portion of the catheter toward the treatment location of the blood vessel opposite the first radial portion; deploying an electrode from the treatment portion; and ablating the blood vessel at the treatment location.
In a one-hundred-seventh aspect, the present disclosure includes the method according to the one-hundred-sixth aspect, wherein the intravascular ultrasound imaging device further comprises: an array of solid-state transducers; one or more flexible circuit elements electrically coupled to the array of solid-state transducers and positioned within a housing of the catheter; and an intravascular ultrasound imaging device wire extending proximally from the one or more flexible circuit elements through the housing of the catheter.
In a one-hundred-eighth aspect, the present disclosure includes the method according to any of the one-hundred-sixth through one-hundred-seventh aspects, wherein the array of solid-state transducers are disposed circumferentially around the housing of the catheter.
In a one-hundred-ninth aspect, the present disclosure includes the method according to any of the one-hundred-sixth through one-hundred-eighth aspects, wherein the biasing mechanism is a balloon.
In a one-hundred-tenth aspect, the present disclosure includes the method according to any of the one-hundred-sixth through one-hundred-ninth aspects, wherein the biasing mechanism is an expandable cage.
In a one-hundred-eleventh aspect, the present disclosure includes the method according to any of the one-hundred-sixth through one-hundred-tenth aspects, wherein the biasing mechanism comprises one or more expandable wires moveable between a collapsed position and an expanded position wherein at least a portion of the one or more expandable wires are spaced from an outer wall of the housing of the catheter.
In a one-hundred-twelfth aspect, the present disclosure includes a system for forming a fistula between two blood vessels, comprising: a first catheter comprising a first catheter body, an electrode, and a biasing stent, wherein: the electrode is configured to project from a treatment portion of the first catheter and define an active side of the first catheter; the biasing stent longitudinally extends along a length of the first catheter body and is configured to radially extend away from the first catheter body between a proximal point and a distal point; and the biasing stent extends from a non-active side of the first catheter body such that the biasing stent is configured to bias the treatment portion against a first blood vessel wall; and a second catheter.
In a one-hundred-thirteenth aspect, the present disclosure includes the system according to the one-hundred-twelfth aspect, wherein the biasing stent comprises: a first tapered section; a second tapered section; and a third section longitudinally positioned between the first tapered section and the second tapered section.
In a one-hundred-fourteenth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-thirteenth aspects, wherein: the first tapered section is coupled to the first catheter body at a proximal point of the first tapered section, and the first tapered section connects to the third section of the biasing stent at a distal point of the first tapered section; and the second tapered section is coupled to the first catheter body at a distal point of the second tapered section, and the second tapered section connects to the third section of the biasing stent at a proximal point of the second tapered section.
In a one-hundred-fifteenth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-fourteenth aspects, wherein when the biasing stent is in an extended configuration: the distal point of the first tapered section is a greater distance from the first catheter body than the proximal point of the first tapered section; and the proximal point of the second tapered section is a greater distance from the first catheter body than the distal point of the second tapered section.
In a one-hundred-sixteenth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-fifteenth aspects, wherein when the biasing stent is in an extended configuration: the first tapered section slopes from the first catheter body to the third section of the biasing stent; and the second tapered section slopes from the first catheter body to the third section of the biasing stent.
In a one-hundred-seventeenth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-sixteenth aspects, wherein the biasing stent comprises an elliptic cross section.
In a one-hundred-eighteenth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-seventeenth aspects, wherein the biasing stent comprises a semi-elliptic cross section.
In a one-hundred-nineteenth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-eighteenth aspects, wherein the first catheter further comprises a sheath configured to be advanced distally to compress the biasing stent against the first catheter body.
In a one-hundred-twentieth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-nineteenth aspects, wherein the biasing stent comprises nitinol, stainless steel, polyether ether ketone, polyethylene terephthalate, polyimide, or polytetrafluoroethylene.
In a one-hundred-twenty-first aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-twentieth aspects, wherein: the biasing stent comprises a plurality of interconnected struts; and the plurality of interconnected struts comprise substantially flat ribbons having a substantially rectangular cross section.
In a one-hundred-twenty-second aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-twenty-first aspects, wherein: the biasing stent comprises a plurality of interconnected struts; and the plurality of interconnected struts comprise a circular cross section.
In a one-hundred-twenty-third aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-twenty-second aspects, wherein the treatment portion is longitudinally positioned between the proximal point and the distal point.
In a one-hundred-twenty-fourth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-twenty-third aspects, wherein the distal point is positioned on the non-active side of the treatment portion.
In a one-hundred-twenty-fifth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-twenty-fourth aspects, wherein the distal point is positioned proximal a distal tip of the first catheter body.
In a one-hundred-twenty-sixth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-twenty-fifth aspects, wherein the biasing stent is rigidly coupled to the first catheter body at the distal point and the proximal point with an adhesive or a polymer.
In a one-hundred-twenty-seventh aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-twenty-sixth aspects, wherein at least one of the proximal point or the distal point at least partially define a track within the first catheter body, and at least a portion of the biasing stent is configured to slide within the track of the first catheter body between an extended position and a low-profile position.
In a one-hundred-twenty-eighth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-twenty-seventh aspects, wherein the first catheter comprises one or more arrays of magnets arranged longitudinally along the first catheter body.
In a one-hundred-twenty-ninth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-twenty-eighth aspects, wherein: the proximal point is positioned proximal a first end of at least one array of the one or more arrays of magnets and the distal point is positioned distal to a second end of the at least one array of the one or more arrays of magnets such that the biasing stent longitudinally spans the at least one array of the one or more arrays of magnets.
In a one-hundred-thirtieth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-twenty-ninth aspects, wherein at least one of the proximal point or the distal point is longitudinally positioned between a first end of at least one array of the one or more arrays of magnets and a second end of the at least one array of the one or more arrays of magnets.
In a one-hundred-thirty-first aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-thirtieth aspects, wherein the first catheter is configured to be positioned within a first blood vessel and the second catheter is configured to be positioned within a second blood vessel adjacent to the first blood vessel.
In a one-hundred-thirty-second aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-thirty-first aspects, wherein the second catheter further comprises a recessed region defining an active side of the second catheter, wherein the recessed region is configured to receive the electrode of the first catheter.
In a one-hundred-thirty-third aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-thirty-second aspects, wherein the second catheter further comprises: a second catheter body; and a second biasing stent, wherein: the second biasing stent longitudinally extends along a length of the second catheter body and is configured to radially extend away from the second catheter body between a proximal point and a distal point; and the second biasing stent extends from a non-active side of the second catheter body such that the second biasing stent is configured to bias the recessed region against a second blood vessel wall.
In a one-hundred-thirty-fourth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-thirty-third aspects, wherein the recessed region is longitudinally positioned between the proximal point and the distal point.
In a one-hundred-thirty-fifth aspect, the present disclosure includes the system of any of the one-hundred-twelfth through one-hundred-thirty-fourth aspects, wherein the second catheter further comprises one or more arrays of magnets arranged longitudinally along the second catheter body.
In a one-hundred-thirty-sixth aspect, the present disclosure includes a catheter, comprising: a catheter body, an electrode, and a biasing stent, wherein: the electrode is configured to project from a treatment portion of the catheter and define an active side of the catheter; the biasing stent longitudinally extends along a length of the catheter body and is configured to radially extend away from the catheter body between a proximal point and a distal point; and the biasing stent extends from a non-active side of the catheter body such that the biasing stent is configured to bias the treatment portion against a first blood vessel wall.
In a one-hundred-thirty-seventh aspect, the present disclosure includes the catheter according to the one-hundred-thirty-sixth aspect, wherein the biasing stent comprises: a first tapered section; a second tapered section; and a third section longitudinally positioned between the first tapered section and the second tapered section.
In a one-hundred-thirty-eighth aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-thirty-seventh aspects, wherein: the first tapered section is coupled to the catheter body at a proximal point of the first tapered section, and the first tapered section connects to the third section of the biasing stent at a distal point of the first tapered section; and the second tapered section is coupled to the catheter body at a distal point of the second tapered section, and the second tapered section connects to the third section of the biasing stent at a proximal point of the second tapered section.
In a one-hundred-thirty-ninth aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-thirty-eighth aspects, wherein when the biasing stent is in an extended configuration: the distal point of the first tapered section is a greater distance from the catheter body than the proximal point of the first tapered section; and the proximal point of the second tapered section is a greater distance from the catheter body than the distal point of the second tapered section.
In a one-hundred-fortieth aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-thirty-ninth aspects, wherein when the biasing stent is in an extended configuration: the first tapered section slopes from the catheter body to the third section of the biasing stent; and the second tapered section slopes from the catheter body to the third section of the biasing stent.
In a one-hundred-forty-first aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-fortieth aspects, wherein the biasing stent comprises an elliptic cross section.
In a one-hundred-forty-second aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-forty-first aspects, wherein the biasing stent comprises a semi-elliptic cross section.
In a one-hundred-forty-third aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-forty-second aspects, further comprising a sheath configured to be advanced distally to compress the biasing stent against the catheter body.
In a one-hundred-forty-fourth aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-forty-third aspects, wherein the biasing stent comprises nitinol, stainless steel, polyether ether ketone, polyethylene terephthalate, polyimide, or polytetrafluoroethylene.
In a one-hundred-forty-fifth aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-forty-fourth aspects, wherein: the biasing stent comprises a plurality of interconnected struts; and the plurality of interconnected struts comprise substantially flat ribbons having a substantially rectangular cross section.
In a one-hundred-forty-sixth aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-forty-fifth aspects, wherein: the biasing stent comprises a plurality of interconnected struts; and the plurality of interconnected struts comprise a circular cross section.
In a one-hundred-forty-seventh aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-forty-sixth aspects, wherein the treatment portion is longitudinally positioned between the proximal point and the distal point.
In a one-hundred-forty-eighth aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-forty-seventh aspects, wherein the distal point is positioned on the non-active side of the treatment portion.
In a one-hundred-forty-ninth aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-forty-eighth aspects, wherein the distal point is positioned proximal a distal tip of the catheter body.
In a one-hundred-fiftieth aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-forty-ninth aspects, wherein the biasing stent is rigidly coupled to the catheter body at the distal point and the proximal point with an adhesive or a polymer.
In a one-hundred-fifty-first aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-fiftieth aspects, wherein at least one of the proximal point or the distal point at least partially define a track within the catheter body, and at least a portion of the biasing stent is configured to slide within the track of the catheter body between an extended position and a low-profile position
In a one-hundred-fifty-second aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-fifty-first aspects, further comprising one or more arrays of magnets arranged longitudinally along the catheter body.
In a one-hundred-fifty-third aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-fifty-second aspects, wherein: the proximal point is positioned proximal a first end of at least one array of the one or more arrays of magnets and the distal point is positioned distal to a second end of the at least one array of the one or more arrays of magnets such that the biasing stent longitudinally spans the at least one array of the one or more arrays of magnets.
In a one-hundred-fifty-fourth aspect, the present disclosure includes the catheter of any of the one-hundred-thirty-sixth through one-hundred-fifty-third aspects, wherein at least one of the proximal point or the distal point is longitudinally positioned between a first end of at least one array of the one or more arrays of magnets and a second end of the at least one array of the one or more arrays of magnets.
In a one-hundred-fifty-fifth aspect, the present disclosure includes a method of forming a fistula between a first blood vessel and a second blood vessel, comprising: advancing a first catheter into the first blood vessel, wherein the first catheter comprises: a first catheter body, an electrode, and a first biasing stent, wherein: the electrode is configured to project from a treatment portion of the first catheter and define an active side of the first catheter; the first biasing stent longitudinally extends along a length of the first catheter body and is configured to radially extend away from the first catheter body between a proximal point and a distal point; and the first biasing stent extends from a non-active side of the first catheter body such that the first biasing stent is configured to bias the treatment portion against a first blood vessel wall; and ablating tissue with the electrode to form the fistula.
In a one-hundred-fifty-sixth aspect, the present disclosure includes the method according to the one-hundred-fifty-fifth aspect, wherein the treatment portion is longitudinally positioned between the proximal point and the distal point.
In a one-hundred-fifty-seventh aspect, the present disclosure includes the method of any of the one-hundred-fifty-fifth through one-hundred-fifty-sixth aspects, further comprising: advancing a second catheter into the second blood vessel; and aligning the electrode of the first catheter with the second catheter.
In a one-hundred-fifty-eighth aspect, the present disclosure includes the method of any of the one-hundred-fifty-fifth through one-hundred-fifty-seventh aspects, wherein the second catheter comprises a recess, wherein aligning the electrode of the first catheter with the second catheter comprises aligning the electrode with the recess.
In a one-hundred-fifty-ninth aspect, the present disclosure includes the method of any of the one-hundred-fifty-fifth through one-hundred-fifty-eighth aspects, wherein: the first catheter further comprises one or more arrays of magnets arranged longitudinally along the first catheter body; the second catheter further comprises a second catheter body and one or more arrays of magnets arranged longitudinally along the second catheter body; and the electrode of the first catheter is aligned with the second catheter via the one or more arrays of magnets of the first catheter and the one or more arrays of magnets of the second catheter.
In a one-hundred-sixtieth aspect, the present disclosure includes the method of any of the one-hundred-fifty-fifth through one-hundred-fifty-ninth aspects, wherein the second catheter further comprises: a second biasing stent, wherein: the second biasing stent longitudinally extends along a length of the second catheter body and is configured to radially extend away from the second catheter body between a proximal point and a distal point; and the second biasing stent extends from a non-active side of the second catheter body such that the second biasing stent is configured to bias the recess against a second blood vessel wall.
In a one-hundred-sixty-first aspect, the present disclosure includes the method of any of the one-hundred-fifty-fifth through one-hundred-sixtieth aspects, wherein the recess is longitudinally positioned between the proximal point and the distal point.
These and additional features provided by the embodiments described herein will be more fully understood in view of the following detailed description, in conjunction with the drawings.
The embodiments set forth in the drawings are illustrative and exemplary in nature and not intended to limit the subject matter defined by the claims. The following detailed description of the illustrative embodiments can be understood when read in conjunction with the following drawings, where like structure is indicated with like reference numerals and in which:
Embodiments as described herein are directed the systems, methods, and catheters for endovascular treatment of a blood vessel. Endovascular treatments may include but are not limited to fistula formation, vessel occlusion, angioplasty, thrombectomy, atherectomy, crossing, drug coated balloon angioplasty, stenting (uncovered and covered), lytic therapy. Accordingly, while various embodiments are directed to fistula formation between two blood vessels, other vascular treatments are contemplated and possible. The figures generally depict various systems, methods, and devices that allow an operator to visualize and determine when a catheter has reached the correct location to provide treatment to the blood vessel (e.g., form a fistula between adjacent blood vessels). In particular, determining when a catheter has reached a desired location for treatment may be very challenging to an operator. In particular, visualization systems (e.g., ultrasound, fluoroscopy, etc.) may include the need of equipment that may be difficult to control while also controlling advancement of one or more catheter's through a vasculature of a patient. Additionally, such equipment may be expensive, leading treatment facilities to only include such visualization systems in operating rooms or the like. Accordingly, systems as described herein will make visualization easier and/or more accessible for various applications.
Additionally, using two catheters to form a fistula or otherwise provide a treatment (e.g., advancing a wire from one blood vessel to another) has been described in U.S. Pat. No. 9,017,323, entitled “Devices and Methods for Forming Fistula,” filed Nov. 16, 2011, hereby incorporated by reference in its entirety; U.S. Pat. No. 9,486,276, entitled “Devices and Methods for Fistula Formation,” filed Oct. 11, 2013, hereby incorporated by reference in its entirety; U.S. Patent Application Publication No. 2014/0276335, entitled Fistula Formation Devices and Methods Therefor,” filed Mar. 14, 2014, hereby incorporated by reference in its entirety; U.S. Patent Application Publication No. 2015/0258308, filed Mar. 13, 2015, hereby incorporated by reference in its entirety; U.S. patent application Ser. No. 15/019,962, entitled Methods for Treating Hypertension, Filed Feb. 9, 2016, hereby incorporated by reference in its entirety; U.S. Patent Application Publication No. 2017/0202616, entitled “Devices and Methods for Forming a Fistula,” filed Jan. 15, 2017, hereby incorporated by reference in its entirety; U.S. Patent Application Publication No. 2017/0202603, entitled “Systems and Methods for Increasing Blood Flow,” Filed Jan. 15, 2017, hereby incorporated by reference in its entirety; U.S. patent application Ser. No. 16/024,241, entitled “Systems and Methods for Adhering Vessels,” filed Jun. 29, 2018, hereby incorporated by reference in its entirety; and U.S. patent application Ser. No. 16/024,345, entitled “Devices and Methods for Advancing a Wire,” filed Jun. 29, 2018, hereby incorporated by reference in its entirety. However, manipulating two catheters while simultaneously trying to trying to visualize the positions of both catheters may be cumbersome for a user. Accordingly, various embodiments described herein are directed to reducing the number of catheters to a single catheter while providing visualization to allow a user to readily determine a location of a treatment portion of a catheter. Moreover, flexibility of the catheters, spacing of vessels, thickness of the vessel walls, and/or the tortuous anatomy of the vessels, may make it difficult to provide sufficient coaptation and/or alignment between vessels for fistula formation. Accordingly, embodiments described herein address the one or more aforementioned limitations.
These and additional features will be discussed in greater detail below.
The vasculature of a potential subject (e.g., patient) may be tortuous. Additionally, each subject's vasculature may vary to provide each subject with uniquely positioned blood vessels (e.g., veins and arteries). Accordingly, in some embodiments, prior to a vascular treatment, systems as described may be used to scan a vasculature at an around a treatment portion of a subject to map the vasculature of the subject and/or determine a proper location for treatment (e.g., fistula formation).
Also shown in
As shown in
In various embodiments, access to the ulnar artery and/or the ulnar vein may be achieved through an access site formed at the wrist or further up the arm into a superficial vein or artery. The catheter(s) may then be advanced through the vasculature to a treatment location. For example, it is often desirable to form a fistula between a vein and an artery proximate to a perforator (e.g., perforating branch 30) to increase blood flow from deep arteries to the superficial veins for such purposes as dialysis. Advancing a catheter from a superficial vein or artery makes accessing the site for fistula formation within the deep arterial/venous system easier.
It is noted that the vasculature within an arm is illustrated for example purposes only. It is contemplated that systems as described herein may be used to treat blood vessels anywhere within a body, human or animal (e.g., bovine, ovine, porcine, equine, etc.). For example, in some embodiments, blood vessels which are targeted and treated may include the femoral artery and femoral vein or the iliac artery and the iliac vein. In other embodiments, treatments between body conduits may not be limited to vein/artery treatments but may include treatment or fistula formation between adjacent veins, adjacent arteries or any other body conduits (e.g., bile ducts, esophagus, etc.).
Catheters
Generally, systems described herein are directed to endovascular treatment of a blood vessel. For example, systems described herein may be useful in measuring, modifying, and/or ablating tissue to form a fistula. The systems described here typically include one or more catheters. The one or more catheters may comprise one or more treatment portions. For fistula formation procedures, the one or more treatment portions may include one or more fistula-forming elements. The catheters described may further comprise elements to aid in visualization and/or alignment of one or more catheters as described in more detail herein. Any suitable catheter or catheters may be used with the systems described herein to form the fistulas other using the methods described herein.
The catheters may have any suitable diameter for intravascular use, such as, for example, about 4 French, about 5.7 French, about 6.1 French, about 7 French, about 8.3 French, between about 4 French and about 9 French, between about 4 French and about 7 French, between about 4 French and about 6 French, or the like.
Referring now to
As noted above,
In some variations, the first catheter 101 may comprise a housing 113, which may help protect other components of the first catheter 101 during fistula formation. For example, when the fistula-forming element 110 comprises an electrode 106 configured to ablate tissue, the housing 113 may comprise one or more insulating materials which may shield or otherwise protect one or more components of the first catheter 101 from heat that may be generated by the electrode 106 during use.
As shown in
In some variations, each of the one or more catheters may include one or more location indicators 119 configured to allow a control unit of the system to determine a location of the treatment portion of the catheter as it is advanced through the vascular of a subject (e.g., patient). For example, in one embodiment, each of the first catheter 101 and the second catheter 103 may include echogenic markers. The echogenic markers may be positioned proximate to the treatment portion of the catheter and may be visible to an imaging device such of an ultrasound imaging device. The echogenic markers may form particular patterns (e.g., a series of different sized echogenic rings with a specific spacing similar to a bar code) which may allow recognition of a particular catheter. Such pattern or ring may include marker bands made from, for example, platinum, iridium, or combinations thereof applied to the catheter proximate to the treatment portion of the catheter. In some embodiments, and as will be described in greater detail below, based on the echogenic markers a control unit, using a imaging device to capture image data of the one or more catheters, may be configured to determine a location of the treatment portion of the one or more catheters. In a two-catheter system such as illustrated in
In some embodiments, in addition to or in lieu of echogenic markers, the catheters 101/103 may include one or more location sensors 121/123, configured to output a signal indicative of a location of the catheter 101/103 (e.g., the treatment portion of the catheter). For example, the location sensor 121/123 may include an active electromagnetic sensor, a passive electromagnetic sensor, a permanent magnet, an RFID device, and or/an ultrasound transceiver. The location sensor 121 may be coupled to or positioned within the housing of the catheter at a position proximate to the treatment portion of the catheter. For example, a location sensor may be positioned longitudinally within the treatment portion 109/116 of the catheter 101/103. In some embodiments, a location sensor may be positioned proximal to and/or distal from the treatment portion 109/116 of the catheter 101/103. As will be described in greater detail below, a control unit may, based on the signal received from the location sensor 121, determine a location of the treatment portion 109/116 of the catheter 101/103 and follow a location of the catheter 101/103 in real time with an imaging device. It is noted that while the one or more location sensors 121/123 are illustrated as being in close proximity to the treatment portion 109/116, the one or more location sensors may be positioned anywhere along the housing of the catheter 101/103.
It is noted that echogenic markers may be advantageous over electrically powered location sensors due to a need for tethering the location sensor to a power source. Accordingly, some echogenic markers may not require connection to a power source.
Catheter 200 may be substantially similar to catheter 101 described above. Similar to the first catheter 101 described in regards to
It is also contemplated that the catheter 200 may include one or more echogenic markers 216 and/or one or more location sensors 218, as described above in regard to
In addition, the catheter 200 may include one or more biasing mechanisms 220. A biasing mechanism 220 may be configured contact a wall of a blood vessel to bias the treatment portion 210 of the catheter 200 into contact with the wall (e.g., at a target treatment location) of the blood vessel. For example, the biasing mechanism 220 may be configured to expand to contact a first radial portion of a host blood vessel to bias the treatment portion 210 toward a second radial portion of the host blood vessel opposite the first radial portion. That is, the biasing mechanism 220 may expand to cause the catheter 200 to move laterally within the host blood vessel to cause the treatment portion 210 (e.g., cutting device, electrode, etc.) to contact a wall of the blood vessel. In some embodiments, the force of the biasing mechanism 220 may alter a shape of the blood vessel to extend the blood vessel in a direction opposite the movement of the biasing mechanism. Accordingly, the one or more biasing mechanisms 220 may be any mechanism configured to move the catheter transversely within a blood vessel to cause the treatment portion of the catheter to contact a treatment location within the blood vessel. Such biasing mechanism 220 may be positioned on opposite sides of the housing 202 from the treatment portion 210 of the catheter 200. Biasing mechanisms 220 may include, but are not limited to, balloons, cages, expandable wires, retracting mechanisms, etc. Various embodiments of biasing mechanisms will be discussed in greater detail with reference to
In some embodiments, the catheter 200 may further include an intravascular imaging device 240 positioned within the housing 202 adjacent to the treatment portion 210. For example, the intravascular imaging device 240 may include intravascular ultrasound (“IVUS”), optical coherence tomography (“OCT”), intracardiac ultrasound (“ICE”), or the like. The intravascular imaging device 240 may be configured to provide a cross-sectional image at the position of the intravascular imaging device 240. As will be described in greater detail herein, the intravascular imaging device 240 may be used to determine a position of the catheter 200 within a blood vessel and/or the rotational alignment of the catheter 200, for example, the treatment portion 210 of the catheter 200. The intravascular imaging device 200 may be coupled to the housing 202 at a position distal to the treatment portion 210, proximal to the treatment portion 210, or longitudinally aligned with and/or within the treatment portion 210 of the catheter 200. In some embodiments, the one or more location sensors 220 may be incorporated in or positioned proximate to the intravascular imaging device 240. Various embodiments of the intravascular imaging device will be described in greater detail with reference to
Referring now to
Furthermore, catheter 500 may include an intravascular imaging device 540. While the intravascular imaging device 540 is illustrated as being position distal to the treatment portion 505 (e.g., electrode 503), the intravascular imaging device 540 may be positioned anywhere along the catheter 500.
As noted above, catheter 600 may include an intravascular imaging device 640. While the intravascular imaging device 640 is illustrated as being position distal to the treatment portion 603 (e.g., electrode 605), the intravascular imaging device 640 may be positioned anywhere along the catheter 600.
As noted above, catheter 700 may include an intravascular imaging device 740. While the intravascular imaging device 740 is illustrated as being position distal to the treatment portion 703 (e.g., electrode 705), the intravascular imaging device 740 may be positioned anywhere along the catheter 700.
As noted above, catheter 4000 may include an intravascular imaging device 4040. While the intravascular imaging device 4040 is illustrated as being position distal to the treatment portion 4003 (e.g., electrode 4005), the intravascular imaging device 4040 may be positioned anywhere along the catheter 4000.
It is noted that each of the embodiments of the biasing mechanism may be positioned in an un-expanded position via a retractable sheath (not shown). In other embodiments, the biasing mechanism may be actuated by an operator.
The catheter 800 may include an intravascular imaging device 840. While the intravascular imaging device 840 is illustrated as being position distal to the treatment portion 808 (e.g., electrode 810), the intravascular imaging device 840 may be positioned anywhere along the catheter 800.
The catheter 900 may include an intravascular imaging device 940. While the intravascular imaging device 940 is illustrated aligned within the treatment portion 908 and aligned with an apex of the electrode 914, the intravascular imaging device 940 may be positioned anywhere along the catheter 900.
In some embodiments, the deflection wire 1011 may comprise a shape memory material wherein in its natural state the deflection wire 1011 deflects out of the housing 1001. For example, the deflection wire 1011 may be a leaf spring. In such embodiments, a user may hold the deflection wire (e.g., with a sheath) in the retracted configuration and when the catheter has reach the desired position, release the deflection wire 1001. In other embodiments, a user may instead manually advance or retract the deflection wire 1011 (e.g., may pulling/pushing a proximal end of the deflection wire 1011), to cause the deflection wire 1011 to retract or extend.
The catheter 1000 may include an intravascular imaging device 1040. While the intravascular imaging device 1040 is illustrated aligned within the treatment portion 1008 and aligned with an apex of the electrode 1014, the intravascular imaging device 1040 may be positioned anywhere along the catheter 1000.
Referring to
The biasing mechanism 1106 may be coupled to the housing 1101 opposite the exit and re-entry points 1122/1124. Accordingly, the biasing mechanism 1106 may bias the exit and re-entry point 1122/1124 into contact with a treatment location within a blood vessel.
In the present embodiment, the intravascular imaging device 1140 may be positioned longitudinally between the exit point and the re-entry point of the housing within the treatment portion 1108 of the catheter 1100. In other embodiments, the intravascular imaging device may be positioned longitudinally proximal or distal from the treatment portion 1108.
Referring now to
In the depicted embodiment, the housing 2008 is substantially similar to the above-described embodiments. However, in the depicted embodiment, the housing 2008 includes a rapid exchange tip 2002 at the distal end 2004, for passing over a guidewire. The housing 2008 may be formed of from any combination of polymers, such as, silicone rubber, nylon, polyurethane, polyethylene terephthalate (PET), latex, thermoplastic elastomers, or the like. In some embodiments, the housing 2008 may be a braided polymer. In some embodiments, the housing 2008 may define a dual lumen. For example, a first lumen 2050 within the housing 2008 may house the electrode wire 2020 of the catheter 2000, while a second lumen 2060 of the housing 2008 may house various other components such as components with respect to the intravascular imaging device 2040, the array of solid-state transducers 2012, wires thereof, or the like. In some embodiments, the first lumen 2050 housing the electrode wire 2020 may include an insulation sleeve, to electrically and/or thermally insulate the electrode wire 2020. In some embodiments, the first lumen 2050 may be positioned radially within the second lumen 2060.
As noted above, the treatment portion 2013 of the catheter 2000 may include an electrode. The electrode may have an electrode housing 2016 positioned within the catheter 2000. The electrode housing 2016 may be positioned within the catheter housing 2008 and generally aligned with the treatment portion 2013. The electrode may radially extend from the catheter housing 2008 at the electrode housing 2016. The electrode may be housed within the electrode housing 2016 when the electrode is in the low-profile configuration. The electrode housing 2016 may define a channel 2026 therethrough for passage of wires for the intravascular imaging device 2040, the array of solid-state transducers 2012, and/or the like.
The array of solid-state transducers 2012 may be piezoelectric ultrasound transducers. In some embodiments, the array of solid-state transducers 2012 may extend around the entire circumference of the catheter housing 2008. In some embodiments, the array of solid-state transducers 2012 may extend around a portion of the circumference of the catheter housing 2008. The array of solid-state transducers 2012 may be fixed in or on the catheter 2000 by any suitable method. The array of solid-state transducers 2012 may be embedded within the catheter housing 2008. In other embodiments, the array of solid-state transducers 2012 may be fixed to the outer surface of the catheter housing 2008. In other embodiments, the array of solid-state transducers 2012 may be friction-fit within the catheter housing 2008. The array of solid-state transducers 2012 may be positioned proximal or distal the fistula forming element 2014, as discussed in more detail below.
The array of solid-state transducers 2012 may be coupled to one or more flexible circuit elements housed within the catheter housing 2008, such as, but not limited to, one or more multiplexing application-specific integrated circuits 2022. The one or more multiplexing application-specific integrated circuits 2022 may be positioned near the array of solid-state transducers 2012 and within the catheter housing 2008. The one or more multiplexing application-specific integrated circuits 2022 may enable front-end processing of data generated by the array of solid-state transducers 2012. Positioning the one or more multiplexing application-specific integrated circuits 2022 near the array of solid-state transducers 2012 and within the catheter housing 2008 may further reduce the cables and/or wires passing back through the catheter housing 2008 to a back-end processor and/or display device. Particularly, an IVUS wire 2024 may extend from the array of solid-state transducers 2012 and/or the one or more multiplexing application-specific integrated circuits 2022 proximally through the catheter housing 2008.
In embodiments, the array of solid-state transducers 2012 may be positioned between the electrode housing 2016 and the distal end 2004 of the catheter 2000. That is, the array of solid-state transducers 2012 may be positioned between the electrode housing 2016 and the rapid exchange tip 2002. In such embodiments, the one or more multiplexing application-specific integrated circuits 2022 may be positioned between the array of solid-state transducers 2012 and the electrode housing 2016. The channel 2026 of the electrode housing 2016 may allow for the IVUS wire 2024 to extend from the multiplexing application-specific integrated circuits 2022, through the electrode housing 2016, and proximally through the catheter housing 2008.
In some embodiments the electrode housing 2016 may be positioned between the array of solid-state transducers 2012 and the distal end 2004 of the catheter 2000. That is, the electrode housing 2016 may be positioned between the array of solid-state transducers 2012 and the rapid exchange tip 2002. In such embodiments, the array of solid-state transducers 2012 may be positioned between the one or more multiplexing application-specific integrated circuits 2022 and the electrode housing 2016.
Referring now to
Once in position, the cutting device 1110 may be advanced along the lumen through the exit point 1122 and into the second blood vessel 1182. In
Referring now to
The catheter 3100 may further include a treatment portion 3135 arranged along the catheter body 3102. The treatment portion 3135, as described herein, refers to a portion of the catheter 3100 positioned along the catheter body 3102 that is configured to modify a blood vessel (e.g., cut, ablate, etc.). In particular, in embodiments of the present disclosure, the catheter 3100 may include a treatment portion 3135 that is configured to form one or more fistulas between a first blood vessel 3300 (
The electrode 3108 may include an exposed ablation surface, which may be activated to ablate tissue, and a lead wire or other conductor attached thereto. Particularly, when activated, current may be supplied to and/or carried from tissue and fluid via the ablation surface to facilitate ablation or vaporization of tissue to form a fistula. In some embodiments, the electrode 3108 may be a spring wire or leaf spring electrode, which may be movable between a low-profile configuration, in which the electrode 3108 is retained within the catheter 3100, and an extended configuration, in which electrode 3108 projects from a surface of the catheter body 3102. The electrode 3108 may or may not be naturally biased to project from the catheter body 3102. When the electrode 3108 is naturally biased to project from the catheter body 3102, a structure, such as a retractable sheath 3160, may be used to hold or maintain the electrode 3108 in a low-profile configuration until deployment is desired. In some embodiments, the catheter body 3102 may comprise one or more insulating materials (not shown) which may shield or otherwise protect the catheter 3100 and its components from heat generated by the electrode 3108 during use.
Still referring to
Still referring to
The arrays of magnets 3104, 3106, and 3150 described herein may be permanent magnets comprising one or more hard magnetic materials, such as but not limited to alloys of rare earth elements (e.g., samarium-cobalt magnets or neodymium magnets, such as N52 magnets) or alnico. In some variations, the arrays of magnets 3104, 3106, and 3150 may comprise anisotropic magnets; in other variations, the arrays of magnets 3104, 3106, and 3150 may comprise isotropic magnetics. In some variations, the arrays of magnets 3104, 3106, and 3150 may be formed from compressed powder. In some variations, a portion of the arrays of magnets 3104, 3106, and 3150 (e.g., a permeable backing) may comprise one or more soft magnetic materials, such as but not limited to iron, cobalt, nickel, or ferrite. It should be appreciated that in systems comprising two catheters, either the first catheter 3100 or the second catheter 3400 (
Generally, the dimensions of the arrays of magnets 3104, 3106, and 3150 described herein may be selected based upon by the size of the catheter 3100 carrying the arrays of magnets 3104, 3106, and 3150, which in turn may be selected based upon the anatomical dimensions of the selected blood vessels through which the catheter 3100 may be advanced. For example, if the catheter 3100 is to be advanced through a blood vessel 3300 (
In embodiments, the outer surfaces of the arrays of magnets 3104, 3106, and 3150 may be flush or in line with the outer surface of the catheter body 3102. In other embodiments, the magnets 3104, 3106, and 3150 may be positioned radially within the catheter body 3102 away from the outer surface of the catheter body 3102. In other embodiments the outer surfaces of the arrays of magnets 3104, 3106, and 3150 may extend a distance radially beyond the outer surface of the catheter body 3102.
Each array of magnets 3104, 3106, 3150 may be fixed in or on the catheter 3100 by any suitable method. For example, in some variations the one or more arrays of magnets 3104, 3106, and 3150 may be embedded in, adhered to, or friction-fit within the catheter 3100.
Still referring to
The biasing stent 3120 may extend longitudinally (e.g. in the direction of the x-axis of the coordinate axes of
In embodiments, the biasing stent 3120 may extend radially from the non-active side 3103 of the catheter 3100. In other words, the proximal point 3130 and distal point 3132 may be positioned along the non-active side 3103 of the catheter body 3102. More particularly, in embodiments, a lateral center point 3137 (
In embodiments, the biasing stent 3120 may include a first tapered section 3121, a second tapered section 3122, and a third section 3123 longitudinally positioned between the first tapered section 3121 and the second tapered section 3122. The first tapered section 3121 may be positioned proximal the second tapered section 3122. The first tapered section 3121 may be coupled to the catheter body 3102 at a proximal point 3124 of the first tapered section 3121. Particularly, the proximal point 3124 of the first tapered section 3121 may be coupled to the catheter body 3102 at the proximal point 3130. The first tapered section 3121 may further connect to the third section 3123 of the biasing stent 3120 at a distal point 3125 of the first tapered section 3121. The second tapered section 3122 may be coupled to the catheter body 3102 at a distal point 3126 of the second tapered section 3122. Particularly, the distal point 3126 of the second tapered section 3122 may be coupled to the catheter body 3102 at the distal point 3132. The second tapered section 3122 may further connect to the third section 3123 of the biasing stent 3120 at a proximal point 3127 of the second tapered section 3122.
As mentioned above, the biasing stent 3120 may radially arch away from the catheter body 3102 of the catheter 3100 between the proximal point 3130 and the distal point 3132. In some embodiments the biasing stent 3120 may be fixedly secured to the catheter body 3102 at the proximal point 3130 and the distal point 3132. In other words, the proximal point 3124 of the first tapered section 3121 may be fixedly secured to the catheter body 3102 at the proximal point 3130, and the distal point 3126 of the second tapered section 3122 may be fixedly secured to the catheter body 3102 at the distal point 3132. In such embodiments, the biasing stent 3120 may be fixed to the catheter body 3102 at the proximal point 3130 and the distal point 3132 with a suitable polymer or adhesive, such as glue, laser welding, heat shrunk plastic wrap, or the like.
In embodiments, the struts 3170 of the biasing stent 3120 may have a circular cross section. In embodiments, the struts 3170 of the biasing stent 3120 may be flat ribbons having a substantially rectangular cross section. In embodiments, the biasing stent 3120 may be made of metal, plastic, polymer, metal coated in plastic, a composite of any of said materials, and the like. For instance, the biasing stent 3120 may be nitinol, stainless steel, polyethylene terephthalate, polyether ether ketone, polytetrafluoroethylene, polyimide, and the like. The biasing stent 3120 may be made of a material that exhibits high radiopacity, allowing the biasing stent 3120 to be visualized under fluoroscopy. The biasing stent 3120 may be a material that exhibits shape memory and returns to a set or desired shape.
In some embodiments, the biasing stent 3120 may expand from a low-profile configuration to an extended configuration, depicted in
When the biasing stent 3120 is in the extended configuration, the distal point 3125 of the first tapered section 3121 is a greater distance from the catheter body 3102 than the proximal point 3124 of the first tapered section 3121. Also, when in the extended configuration, the proximal point 3127 of the second tapered section 3122 is a greater distance from the catheter body 3102 than the distal point 3126 of the second tapered section 3122. Therefore, when the biasing stent 3120 is in the extended configuration, the first tapered section 3121 slopes from the catheter body 3102 to the third section 3123 of the biasing stent 3120, and the second tapered section 3122 slopes from the catheter body 3102 to the third section 3123 of the biasing stent 3120. In embodiments, a radially outer edge 3142 of the first tapered section 3121 may linearly slope from the non-active side 3103 of the catheter body 3102 to a radially outer edge 3146 of the third section 3123 of the biasing stent 3120, and a radially outer edge 3144 of the second tapered section 3122 may linearly slope from the non-active side 3103 of the catheter body 3102 to the radially outer edge 3146 of the third section 3123 of the biasing stent 3120. The sloped first tapered section 3121 and second tapered section 3122 may allow the catheter 3100, with the biasing stent 3120 exposed, to be advanced and retracted in the blood vessel 3300 (
In embodiments, the biasing stent 3120 described herein may be biased toward the extended configuration. That is, the biasing stent 3120 may be configured to self-expand from the low-profile configuration to the extended configuration. Put yet another way, the biasing stent 3120 may be in its natural resting state in the extended configuration, extending a predetermined distance away from the outer surface of the catheter body 3102. In such embodiments, a force may be required to hold the biasing stent 3120 in the low-profile configuration. For instance, referring to
In some embodiments, the biasing stent 3120 may be made of a shape-memory alloy, such as copper-aluminum-nickel and nickel-titanium, that changes shape due to environmental cues, such as temperature. For instance, the active shape of the biasing stent 3120 may be the extended configuration depicted in
Referring now to
In some embodiments, the biasing stent 3120 described herein may be configured such that the biasing stent 3120 is longitudinally moveable (e.g. in the direction of the x-axis of
The proximal point 3124 (
In the low-profile configuration, as depicted in
In embodiments, the biasing stent 3120 may be biased to the extended configuration. In other words, the anchor member 3210, and the proximal point 3124 (
It should be appreciated that, in embodiments, the biasing stent 3120 may be fixed to the catheter body 3102 at the distal point 3132 and slide within the track 3200 from the proximal point 3130. In other embodiments, the biasing stent 3120 may similarly be fixed to the catheter body 3102 at the proximal point 3130 and slide within a track 3200 from the distal point 3132. In such embodiments, the distal point 3132 may define at least a portion of the track 3200 in the catheter body 3102. More particularly, the distal point 3132 may define a proximal end of the track 3200. The biasing stent 3120 may move distally (e.g. in the +x direction of the coordinate axes of
In the embodiments of the catheter 3100 discussed, the natural bias of the biasing stent 3120 may eliminate the need for a user-actuated control that in a first state holds the biasing stent 3120 in a low-profile configuration for delivery through the vasculature and in a second state allows the biasing stent 3120 to enter the extended configuration for applying a biasing force to the wall of the blood vessel 3300 (
Referring now to
Referring now to
The one or more arrays of magnets 3104, 3106, 3150 of the first catheter 3100 and the one or more arrays of magnets 3404, 3406, 3450 of the second catheter 3400 may be configured to promote rotational and axial alignment of the catheters 3100 and 3400. Proper axial and rotational alignment between catheters 3100 and 3400 may facilitate alignment of one or more fistula-forming elements, such as the treatment portions 3135, 3435 of the first and second catheters 3100, 3400, respectively. More specifically, proper axial and rotational alignment between the first catheter 3100 and the second catheter 3400 may facilitate alignment of the electrode 3108 with the recess 3408. The one or more arrays of magnets 3104, 3106, 3150 of the first catheter 3100 may be arranged such that the magnetic fields generated by the one or more arrays of magnets 3104, 3106, 3150 are stronger in the direction of the active side 3134 of the treatment portion 3135 (e.g. in the −z direction of the coordinate axes of
The catheters 3100 and 3400, as depicted in
Each array of magnets 3404, 3406, 3450 of the second catheter 3400 may be configured to mate with a corresponding array of magnets 3104, 3106, 3150 of the first catheter 3100, and vice versa, such that the first catheter 3100 and the second catheter 3400 may be aligned and coapted. As used herein, the terms “coapted” and/or “strong coaptation” may be understood to mean that the first catheter 3100 and the second catheter 3400 are in close approximation (e.g. in the direction of the z-axis of the coordinate axes of
During a fistula-forming procedure, however, the one or more arrays of magnets 3104, 3106, and 3150 of the first catheter 3100 and the one or more arrays of magnets 3404, 3406, and 3450 of the second catheter 3400 may be insufficient on their own to align and coapt the first catheter 3100 and the second catheter 3400. For instance, due to limitations in the strength of the one or more arrays of magnets 3104, 3106, 3150 of the first catheter 3100 and the one or more arrays of magnets 3404, 3406, 3450 of the second catheter 3400, limitations on the degree of flexibility of the first catheter 3100 and the second catheter 3400, a distance between the vessels 3300 and 3302, and/or a tortuous anatomy of the first blood vessel 3300 and/or the second blood vessel 3302, the one or more arrays of magnets 3104, 3106, 3150 of the first catheter 3100 and the one or more arrays of magnets 3404, 3406, 3450 of the second catheter 3400 may be unable to mate. Therefore, as depicted in
The biasing stent 3120 of the first catheter 3100 and/or the biasing stent 3420 of the second catheter 3400 may assist the one or more arrays of magnets 3104, 3106, 3150 of the first catheter 3100 and the one or more arrays of magnets 3404, 3406, 3450 of the second catheter 3400 in aligning and coapting the first catheter 3100 and the second catheter 3400. For instance, referring to
Referring now to
In embodiments in which the biasing stents 3120 and 3420 are naturally biased from the low-profile configuration to the extended configuration, the biasing stents 3120 and 3420 may begin to extend radially away from the catheter bodies 3102 and 3402, respectively. For instance, the biasing stent 3120 may extend toward the maximum height of the extended configuration until the biasing stent 3120 contacts a wall of the blood vessel 3300. Accordingly, the biasing stent 3120 may apply a biasing force against the wall of the blood vessel 3300, resulting in a biasing reaction force to be applied to the catheter 3100 to push the active side 3134 and/or the one or more magnetic arrays against a wall of the blood vessel 3300. More specifically, as the lateral center point 3137 (
Similarly, the biasing stent 3420 of the second catheter 3400 may transition to the extended configuration to contact a wall of the second blood vessel 3302, resulting in a biasing reaction force that directs the active side 3434 of the treatment portion 3435 of the second catheter 3400 against a wall of the second blood vessel 3302. For example, the biasing stent 3420 of the second catheter 3400 may be deployed when the active side 3434 of the treatment portion 3435 of the second catheter 3400 is substantially aligned with the active side 3134 of the treatment portion 3135 of the first catheter 3100. Accordingly, the biasing stents 3120 and 3420 may strengthen the coaptation between the first catheter 3100 and the second catheter 3400. For example, and as described above, the biasing stent 3120 of the first catheter 3100 may bias, in addition to the active side 3134 of the treatment portion 3135, the one or more arrays of magnets 3104, 3106, 3150 against the wall of the first blood vessel 3300, and the biasing stent 3420 of the second catheter 3400 may bias, in addition to the active side 3434 of the treatment portion 3435, the one or more arrays of magnets 3404, 3406, 3450 against the wall of the second blood vessel 3302 thereby increasing attraction between the one or more arrays of magnets 3104, 3105, 3150 of the first catheter 3100 with the one or more arrays of magnets 3404, 3406, 3450 of the second catheter 3400 by decreasing distance between them. For example, once in closer approximation, the one or more arrays of magnets 3104, 3106, 3150 of the first catheter 3100 and the one or more arrays of magnets 3404, 3406, 3450 of the second catheter 3400 may be able to mate, overcoming any previous barriers, such as the distance between magnets, the flexibility of the catheters 3100, 3400, the distance between the vessels 3300, 3302, the tortuous anatomy of the first and second blood vessels 3300, 3302, and/or the like. The mating of the one or more arrays of magnets 3104, 3106, 3150 of the first catheter 3100 and the one or more arrays of magnets 3404, 3406, 3450 of the second catheter 3400 may coapt and align the catheters 3100 and 3400. After the first catheter 3100 and the second catheter 3400 are coapted and aligned, the electrode 3108 may be advanced and energized to ablate the wall of the first blood vessel 3300 and the wall of the second blood vessel 3302 and advance into the recess 3408 of the second catheter 3400, thereby forming a fistula between the first and second blood vessels 3300, 3302.
In other embodiments, only one of the catheters 3100, 3400 may be used in a method for forming a fistula between the first blood vessel 3300 and the second blood vessel 3302. For instance, a contrast dye may be injected into the second blood vessel 3302, such that the second blood vessel 3302 is visible under fluoroscopy. The first catheter 3100 may then be advanced in the first blood vessel 3300 until the treatment portion 3135 is generally aligned with a desired site to form a fistula between the first and second blood vessels 3300, 3302. The biasing stent 3120 may be made of a material that exhibits high radiopacity, allowing the biasing stent 3120 of the first catheter 3100 to be visualized under fluoroscopy, aiding a user in identifying the position of the biasing stent 3120 and the treatment portion 3135 of the first catheter 3100 in the first blood vessel 3300. The biasing stent 3120 of the first catheter 3100 may transition from the low-profile configuration to the extended configuration by any device or method discussed with reference to
Referring now to
Systems and Methods
Various systems and methods will now be described including the various embodiments of the above-described catheters. It is noted that while only specific embodiments may be illustrated within the figures. The present system and methods may be applicable to any of the catheter systems described herein.
The various modules of the system 1200 may be communicatively coupled to one another over the communication path 1202. The communication path 1202 may be formed from any medium that is capable of transmitting a signal such as, for example, conductive wires, conductive traces, optical waveguides, or the like. Moreover, the communication path 1202 may be formed from a combination of mediums capable of transmitting signals. In some embodiments, the communication path 1202 includes a combination of conductive traces, conductive wires, connectors, and buses that cooperate to permit the transmission of electrical data signals between the various components of the components such as processors, memories, sensors, input devices, output devices, and communication devices. Additionally, it is noted that the term “signal” means a waveform (e.g., electrical, optical, magnetic, mechanical or electromagnetic), such as DC, AC, sinusoidal-wave, triangular-wave, square-wave, vibration, and the like, capable of traveling through a medium.
The control unit 1204 can be any type of computing device and includes one or more processors and one or more memory modules. The one or more processors may include any device capable of executing machine-readable instructions stored on a non-transitory computer-readable medium, such as those stored on the one or more memory modules. Accordingly, each of the one or more processors may include a controller, an integrated circuit, a microchip, a computer, and/or any other computing device.
The one or more memory modules of the control unit 1204 are communicatively coupled to the one or more processors. The one or more memory modules may be configured as volatile and/or nonvolatile memory and, as such, may include random access memory (including SRAM, DRAM, and/or other types of RAM), flash memory, secure digital (SD) memory, registers, compact discs (CD), digital versatile discs (DVD), and/or other types of non-transitory computer-readable mediums. Depending on the particular embodiment, these non-transitory computer-readable mediums may reside within the control unit 1304, as shown, and/or external to the control unit 1304. The one or more memory modules may be configured to store logic (i.e., machine readable instructions) that, when executed by the one or more processors, allow the control unit to perform various functions that will be described in greater detail below.
The imaging device 1206 may be any imaging device configured to capture image data of the one or more catheters and surrounding vasculature as the catheter is advanced through the blood vessel. For example, and as described above, the imaging device 1306 may be an intravascular imaging device (e.g., IVUS, ICE, OCT, etc.) coupled to the housing of the catheter. Intravascular imaging devices are described in greater detail above. In other embodiments, the imaging device 1306 may be an external imaging device such as, for example an ultrasound device (e.g., a 2D ultrasound device and/or a 3D ultrasound device).
The imaging device 1206 may be communicatively coupled to the control unit over the communication path. Based on the data received from the imaging device 1306, the control unit may be able to process the image data to determine the rotational orientation of the catheter, and more specifically, the rotational orientation of the treatment portion of the catheter. In two catheter systems, the control unit may be able to determine proper alignment (e.g., longitudinal, rotational, and distance) between the two catheters for delivery of a vascular treatment.
As noted above, the system 1200 further includes a display 1240 communicatively coupled to the other modules of the system 1200 over the communication path 1202. The display 1240 may be any type of display configured to display image data from the imaging device 1206. In some embodiments, the control unit 1204 may process image data and with the display, project indicators onto the image to indicate, for example, rotational alignment, longitudinal alignment, distance between blood vessels, blood vessel labels (artery, catheter, perforator, etc.), etc. In embodiments wherein the imaging device comprises Doppler functionality, the control unit may be configured to display Doppler information include flow rate, volume, vessel pressure, etc. In various embodiments, the control unit may display the treatment portion of the catheter in real time as the treatment portion is advanced through the vasculature of the patient.
As discussed herein, methods may include selection of a blood vessel for access. As noted above, access to a vein or artery may be provided at the wrist or elsewhere. The catheter may be advanced through the blood vessel to a desired location, such as proximate to a perforator. For example, with reference to
As noted above, the control unit 1204 may be configured to determine a rotational positon of the catheter, and more specifically the treatment portion of the catheter. For example, and as noted above the catheter C may include one or more location sensors (e.g., including information from an intravascular imaging device as described herein) and/or echogenic markers that may be discernable by (e.g., through image recognition processing) or communicatively coupled to the control unit 1204. The one or more location sensors and/or echogenic markers may allow the system to follow and/or track the orientation and/or location of the treatment portion (e.g., the electrode) of the catheter C and produce an overlay such as illustrated in
Once in the desired alignment as the operator may determine from the display and overlay projected on the display, the operator can deploy the biasing mechanism D, such as discussed above, to bias the treatment portion into contact with the treatment location of the blood vessel, as illustrated in
It is noted that while the above-provided example is directed to fistula formation using a single catheter, other treatments are contemplated and possible. Additionally, systems incorporating two catheters may similarly be used. In such cases, each catheter may include an intravascular imaging device and an overlay may provide rotational orientation of both of the catheters.
However, as noted herein, in various embodiments, the imaging device may not be an intravascular imaging device. In such embodiments, and as will be described in greater detail below, an actuator may be coupled to the imaging device and communicatively coupled to the control unit such that the control unit can control motion of the imaging device through the actuator. In such embodiments, the control unit will follow a position of the treatment portion of the catheter with the imaging device such that real-time imaging of the treatment portion of the catheter may be shown on the display without the need for direct operator control of the imaging device.
Referring still to
Referring now to
Referring collectively to
In some embodiments, the catheter tracking sensor 1380 may interact with a location sensor incorporated into the one or more catheters. For example, the catheter tracking sensor 1380 may be able to detect a signal output by the location sensor incorporated into the catheter to follow the location of the treatment portion of the catheter. In some embodiments, the system 1300 may include an electromagnetic field generator board 1360 that will generate an electromagnet field to facilitate tracking between the catheter tracking sensor 1340 and the location sensor of the catheter. Such electromagnetic field generator board 1360 may be situated, for example, underneath a treatment portion of the user to generator an electromagnetic field around the treatment portion of the user. Referring to
As noted herein, based on the signals of the location sensor and/or the tracking sensor 1340, the control unit 1304 may determine a location of the treatment portion of the catheter and may be configured to automatically focus the settings of the imaging device to display various views of the treatment portion of the catheter including a sagittal view, an axial view, and/or a frontal view. For example, based on the signal of the location sensor, the control unit may automatically track a depth of the sensor and adjust image quality settings. Such views may cut through a center of the treatment portion of the catheter, such that each view shows a cross-sectional view of the catheter along in the sagittal plane, axial plane, and/or the frontal plane.
Referring again to
As noted above, the system 1300 may further include an actuator 1340 communicatively coupled to the control unit 1304 and physically coupled to the imaging device 1306 (e.g., ultrasound probe 1320). As noted herein, the control unit 1304 may be configured to move the imaging device 1306 with the actuator 1340.
When using an external ultrasound imaging device, the ultrasound probe 1320 may include a subject contact surface 1322. The subject contact surface 1322 may be contacted to a treatment zone (e.g., arm, leg, torso, etc.) of a subject through a flexible subject interface/fluid barrier. That is, the subject contact surface 1322 may directly contact a treatment zone (e.g., arm, leg, etc.) of a patient or may directly contact the flexible fluid barrier 1408, which is directly contacted with the treatment zone of the subject. Such fluid barrier may be provided s part of a media bath 1400 configured to be placed over the treatment zone of a subject. For example, the media bath 1400, such as illustrated in
Once the subject 1500 is positioned, the robotic arm 1342 may be controlled either manually or automatically based on logic executed by the control unit 1304, to place the ultrasound probe within the media bath 1400 and in contact the subject contact surface 1322 with the subject 1500. In various embodiments, the system 1300 may be used without catheters to first map a vasculature of the subject to seek a desired location for vascular treatment (e.g., fistula formation). As noted herein, the system 1300 may be placed in an automatic catheter following mode, wherein the control unit 1304 automatically controls the robotic arm 1342 to cause the ultrasound probe 1306 to follow a position of a treatment portion of the catheter as it is advanced through the vasculature of subject to a target treatment location.
Referring again to
As noted above, in some embodiments, the systems as provided herein may be used to scan a perspective anatomical region to build a venous and/or arterial 2D or 3D map and display such map on a display. For example, and as noted above, Doppler functionality may be used to allow the system to determine arterial and venous blood flows (e.g., Doppler functions may measure flow direction, velocity, etc. to allow for determination). The control unit may execute logic to build and 2D or 3D arterial map. In some embodiments, the generated 2D or 3D map may use different colors (e.g., red/blue) to illustrate venous and/or arterial blood flow. Furthermore, when a catheter is advanced through the system it may be shown on the generated the map as it is advanced through the vasculature. Such mapping may be integrated into a larger vessel map (e.g., vessel map of entire arm, leg, body, etc.) to allow a physician to contemplate an entire anatomy of a subject to determine proper treatment locations/zones. Success of treatment may be identified or confirmed using Doppler and indicated on the 2D or 3D map. For example, where a fistula is created, Doppler functionality may be used to identify new flow between adjacent vessels to determine a fistula has been created and adjust the 2D or 3D map to illustrate the same.
In some embodiments, though not shown during vascular treatment, a guidewire having an integrated tracking sensor close to its tip may be inserted into the desired vein or artery and advanced to a target treatment location under guidance of the imaging device. The catheter may then be advanced to the target treatment location over the guidewire using the one or more location sensors as described herein, or the one or more echogenic markers or rings, the treatment portion of the catheter may be tracked and displayed using the display device in real time with or without the use of fluoroscopy.
As noted herein in various embodiments overlays may be positioned over images from the imaging device and displayed on the display to provide indications as to rotational alignment, longitudinal alignment, and distance (e.g., between blood vessels and/or catheters). Additionally, the overlays may also allow a user to determine if the treatment portion in contact with the treatment location within the blood vessel. For example, and as described in greater detail above, a biasing mechanism may be activated to bias the catheter into the correct position within the vessel to deliver treatment (e.g., form a fistula).
In determining proximity, the control unit may track a location of each of the first and second treatment portions 110/116 based on signals from the one or more location sensors 121A/121B/123A/123B and/or the one more tracking sensors discussed above. Based on these signals, the control unit may determine whether or not the catheters are positioned within a predetermined distance such that fistula formation is position (e.g., less than 2 mm).
It is noted, that the external imaging devices described herein may be similarly used for tracking and locating a single catheter system.
As noted herein, devices and methods as provided herein may be used for purposes other than fistula formation. For example, the devices as provided herein may be used for vasculature mapping purpose, arterializing purposes (e.g., arterializing a vein for ischemia in the leg), vessel occlusion, angioplasty, thrombectomy, atherectomy, crossing, drug coated balloon angioplasty, stenting (uncovered and covered), lytic therapy, etc. In addition, methods provided herein, may include multiple treatments and or multiple treatment sites.
It should now be understood that embodiments as described herein are directed the systems, methods, and catheters for endovascular treatment of a blood vessel. In particular, embodiments as described herein include imaging devices (e.g., external or endovascular imaging devices) that provide real-time imaging of a catheter to allow an operator to quickly and efficiently determine the position and alignment of a treatment portion of a catheter. Moreover, embodiments described herein may allow for use of a single catheter for such treatment as fistula formation. Thus simplifying such procedures for operators and patients alike.
It is noted that the terms “substantially” and “about” may be utilized herein to represent the inherent degree of uncertainty that may be attributed to any quantitative comparison, value, measurement, or other representation. These terms are also utilized herein to represent the degree by which a quantitative representation may vary from a stated reference without resulting in a change in the basic function of the subject matter at issue.
While particular embodiments have been illustrated and described herein, it should be understood that various other changes and modifications may be made without departing from the spirit and scope of the claimed subject matter. Moreover, although various aspects of the claimed subject matter have been described herein, such aspects need not be utilized in combination. It is therefore intended that the appended claims cover all such changes and modifications that are within the scope of the claimed subject matter.
This application claims the benefit of co-pending U.S. Provisional Patent Application No. 63/119,239 filed Nov. 30, 2020 for “Systems, Methods, and Catheters for Endovascular Treatment of a Blood Vessel,” which is hereby incorporated by reference in its entirety.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2021/061118 | 11/30/2021 | WO |
| Number | Date | Country | |
|---|---|---|---|
| 63119239 | Nov 2020 | US |
